A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars

Trial Profile

A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars

Discontinued
Phase of Trial: Phase II

Latest Information Update: 10 Aug 2016

At a glance

  • Drugs Azficel-T (Primary)
  • Indications Scars; Skin disorders
  • Focus Registrational; Therapeutic Use
  • Sponsors Fibrocell Technologies
  • Most Recent Events

    • 07 Jul 2016 Status changed from active, no longer recruiting to discontinued as they were unable to enroll.
    • 26 Jan 2016 Planned End Date changed from 1 Dec 2015 to 1 Jul 2016, as reported by ClinicalTrials.gov record.
    • 26 Jan 2016 Planned primary completion date changed from 1 Oct 2015 to 1 May 2016, as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top